✦ LIBER ✦

Safety Evaluation of Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency

✍ Scribed by Staubach, P.; Bork, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Icatibant, a Selective Bradykinin B2 Rec

✍ Bork, K. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Icatibant, a Selective Bradykinin-B2 Rec

✍ Bork, K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Icatibant, a Selective Bradykinin B2 Rec

✍ RIEDL, M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Successful treatment of acute angioedema

✍ Andrea Zanichelli; Matteo Badini; Ilaria Nataloni; Marco Cicardi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Efficacy and Tolerability of Icatibant A

✍ Prior, N.; Caminoa, M.; Gómez-Traseira, C.; López-Serrano, M.; Caballero, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Clinical Evaluation of Tolerance and Vir

✍ Bulnes, M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB